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Abstract
Dilute ethanol (EtOH) is a widely used agent to remove the corneal epithelium during the modern refractive surgery. The
application of EtOH may cause the underlying corneal fibroblasts to undergo apoptosis. This study was designed to
investigate the protective effect and potential mechanism of the respiratory chain coenzyme Q10 (CoQ10), an electron
transporter of the mitochondrial respiratory chain and a ubiquitous free radical scavenger, against EtOH-induced apoptosis
of corneal fibroblasts. Corneal fibroblasts were pretreated with CoQ10 (10 mM) for 2 h, followed by exposure to different
concentrations of EtOH (0.4, 2, 4, and 20%) for 20 s. After indicated incubation period (2–12 h), MTT assay was used to
examine cell viability. Treated cells were further assessed by flow cytometry to identify apoptosis. Reactive oxygen species
(ROS) and the change in mitochondrial membrane potential were assessed using dichlorodihydrofluorescein diacetate
/29,79-dichlorofluorescein (DCFH-DA/DCF) assays and flow-cytometric analysis of JC-1 staining, respectively. The activity and
expression of caspases 2, 3, 8, and 9 were evaluated with a colorimetric assay and western blot analysis. We found that EtOH
treatment significantly decreased the viability of corneal fibroblasts characterized by a higher percentage of apoptotic cells.
CoQ10 could antagonize the apoptosis inducing effect of EtOH. The inhibition of cell apoptosis by CoQ10 was significant at 8
and 12 h after EtOH exposure. In EtOH-exposed corneal fibroblasts, CoQ10 pretreatment significantly reduced mitochondrial
depolarization and ROS production at 30, 60, 90, and 120 min and inhibited the activation and expression of caspases 2 and
3 at 2 h after EtOH exposure. In summary, pretreatment with CoQ10 can inhibit mitochondrial depolarization, caspase
activation, and cell apoptosis. These findings support the proposition that CoQ10 plays an antiapoptotic role in corneal
fibroblasts after ethanol exposure.
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Introduction
The excimer laser is an effective tool, not only for correcting
myopic refractive error, but also for treating various types of
anterior corneal pathology [1]. The success of excimer laser
refractive surgery, including photorefractive surgery (PRK) and
laser subepithelial keratomileusis (LASEK), depends on thorough
preoperative assessment and attention to intraoperative details.
However, myopic regression and prolonged visual rehabilitation are
two common consequences of these surface ablations [2]. Although
individual differences often result in variable corneal wound healing
after refractive surgery, the methods of corneal epithelial removal
used in these refractive procedures can also affect the occurrence of
these undesirable outcomes [3]. The application of diluted ethanol
(EtOH) is one of the most widely used methods to remove the
epithelium during the procedures of surface ablation [2,4]. Ethanol
delamination of the corneal epithelium consistently results in very
smooth cleavage at the level of the hemidesmosomal attachments,
including the superficial lamina lucida, and is used to create a
smooth stromal surface for further surface ablation [5].
The corneal stromal cell apoptosis has been well-characterized
as an early initiating event of the corneal healing response during
refractive surgery [6,7]. It triggers subsequent cellular processes
that include bone marrow-derived cell infiltration, proliferation of
residual corneal stromal cells, and in some circumstances,
generation of myofibroblasts [6,8]. Ethanol may induce apoptosis
in a variety of tissues, including corneal epithelial cells [9,10],
corneal keratocytes [11], Liver [12], and brain [13]. Adverse
effects of alcohol on corneal fibroblasts have been reported,
including apoptotic changes in the anterior stromal keratocytes,
especially around the epithelial flap margin, and these can result in
cell loss after treatment [7,14,15]. In the cornea, the apoptosis of
corneal fibroblasts induced by ethanol plays an important role in
the chemokinetics of corneal wound healing [16], myofibroblast
transformation [17], and corneal neovascularization [18]. Modu-
lation of cell apoptosis in the corneal stroma is thought to be
critical for ideal refractive surgery, with early stromal cell apoptosis
regarded as a promising target for controlling later events in the
wound healing cascade [8]. To date, pharmacological efforts to
control early corneal stromal cell apoptosis have not been
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regulate this phenomenon.
Recent studies have demonstrated that free radical formation
increases after excimer laser surgery [19,20,21]. The exposure of
cells to ethanol can alter the cytosolic and mitochondrial redox
states and disrupt the functions of various metabolic pathways,
which also increase free radical formation [21]. Antioxidants and
free radical scavengers have been reported to protect the cornea
from the harmful effects of free radicals [22,23]. The protective
effects of ascorbic acid and vitamin E after PRK have been
demonstrated in previous studies [23,24]. Ubiquinone Q10
(coenzyme Q10, CoQ10) is a well-known electron transporter in
complexes I (NADH–ubiquinone oxidoreductase), II (succinate–
ubiquinone oxidoreductase), and III (ubiquinone–cytochrome c
oxidoreductase) of the mitochondrial respiratory chain [25,26].
CoQ10 is also a ubiquitous free radical scavenger that inhibits
cellular apoptosis [25,27,28,29,30]. Brancato et al have demon-
strated that CoQ10 reduces the number of apoptotic keratocytes
produced in response to excimer laser irradiation to a much
greater extent than do other free radical scavengers, such as
ascorbic acid and vitamin E [31]. CoQ10 also plays a role in the
control of mitochondrial transition pore opening, which is
involved in apoptosis [32].
In this study, we hypothesized that CoQ10 pretreatment
increases cell viability and reduces cell apoptosis in corneas
exposed to ethanol during refractive surgery. Therefore, we
evaluated the effects of CoQ10 pretreatment on ethanol-exposed
corneal fibroblasts in vitro.
Results
Effect of coenzyme Q10 on ethanol-treated corneal
fibroblast viability
To assess the changes in cell viability after EtOH exposure, we
evaluated its dose- and time-dependent effects on cultured corneal
fibroblasts with or without CoQ10 pretreatment. At lower
concentrations of EtOH, i.e., ,20%, EtOH exposure alone
decreased cell viability at indicated concentrations (Table 1). Cell
viability was significantly reduced at 4 h in the 4% EtOH group,
at 8, 12 h in 0.4%, 2%, and 4% EtOH groups. The pretreatment
with CoQ10 significantly increased cell viability at 8, 12 h in 0.4%,
2%, and 4% CoQ10/EtOH groups (Table 1 and Figure 1).
Whereas, at the higher concentration of EtOH, i.e., 20%, the
percentages of cell viability measured at 2, 4, 8 and 12 h after
treatment with 20% EtOH for 20 s were as follows: 2 h,
90.7160.12%; 4 h, 86.2263.56%; 8 h, 29.5864.78%; 12 h,
5.2363% (one-way ANOVA, P,0.05; Figure 1D). The viability
of the EtOH-exposed (20%, 20 s) cells was significantly reduced
compared with that of the control group at all time points (2 h,
P=0.02; 4 h, P=0.03; 8 h, P,0.0001; 12 h, P,0.0001). The
percentage of cell viability was increased in cells pretreated with
CoQ10 after EtOH exposure (2 h, 93.660.57%; 4 h,
94.4360.12%; 8 h, 80.5862.98%; 12 h, 65.1161.39%). The
protective effect of CoQ10 was significant at 8 and 12 h after
EtOH treatment (2 h, P=0.1; 4 h, P=0.1; 8 h, P=0.01; 12 h,
P=0.002).
Table 1. Effect of CoQ10 on cell viability measured by the MTT assay in corneal fibroblasts.
Group Incubation interval (h) Cell viability
a (% of control) P value vs control P value vs EtOH group
Control 4 100
0.4% EtOH 4 89.6564.45% 0.08
CoQ10/0.4%EtOH 4 92.8567% 0.6
2% EtOH 4 89.6062.69% 0.06
CoQ10/2%EtOH 4 95.4062.12% 0.09
4% EtOH 4 87.9561.34%
b 0.01
CoQ10/4%EtOH 4 97.5065.51% 0.05
Control 8 100
0.4% EtOH 8 66.6862.31%
b 0.002
CoQ10/0.4%EtOH 8 80.1263.81%
c 0.01
2% EtOH 8 68.3161.96%
b 0.001
CoQ10/2%EtOH 8 83.6460.81%
c 0.009
4% EtOH 8 62.6262.84%
b 0.003
CoQ10/4%EtOH 8 91.71615.97%
c 0.02
Control 12 100
0.4% EtOH 12 57.4765.76%
b 0.009
CoQ10/0.4%EtOH 12 83.2561.4%
c 0.025
2% EtOH 12 54.9864.08%
b 0.004
CoQ10/2%EtOH 12 81.03610.5%
c 0.032
4% EtOH 12 52.9163.85%
b 0.003
CoQ10/4%EtOH 12 79.61621.65%
c 0.04
aCells were pretreated with 10 mM of CoQ10 before different concentrations of EtOH (0.4%, 2%, 4%) exposure for 20 s and then cell viability was measured by MTT assay
after 4, 8, and 12 h.
bP,0.05, compared with control group.
cP,0.05, compared with EtOH group.
doi:10.1371/journal.pone.0019111.t001
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ethanol-treated corneal fibroblasts
To determinethe effectsof CoQ10on programmedcellulardeath
after EtOH exposure, we analyzed cell apoptosis with annexin V-
FITC and PI double staining methods after incubation for 4, 8, or
12 h (Figure 2). EtOH exposure induced remarkable number of
apoptotic cells upon 4, 8, and 12 h of incubation period. Treatment
of EtOH at the concentrations of 0.4–4% showed a significant
increase in apoptotic cells over the untreated cells after 4, 8, and
12 h. The pretreatment with CoQ10 significantly decreased the
percentage of apoptotic cells induced by EtOH at 8 and 12 h time
points (Table 2 and Figure 2A–2C). As shown in Figure 2D–2E, the
percentages of annexin V–FITC-positive cells after EtOH exposure
(20%, 20 s) were as follows: 4 h, 15.4763.4%; 8 h, 21.0369.0%;
12 h, 29.862.2% (one-way ANOVA, P,0.05). Cell apoptosis was
significantly increased after EtOH exposure compared with that in
the control group at all time points (4 h, P=0.01; 8 h, P=0.01;
12 h, P=0.02). The percentages of EtOH-induced apoptosis were
also attenuated by pretreatment with CoQ10 (4 h, 12.8764.1%;
8 h, 14.6362.11%; 12 h, 17.6266.48%). CoQ10 pretreatment
significantly reduced cell apoptosis at 8 and 12 h after EtOH
exposure (4 h, P=0.1; 8 h, P=0.01; 12 h, P,0.0001).
Effects of coenzyme Q10 on the ROS induced by ethanol
treatment
The results of the DCF assay indicated that EtOH exposure
(20%, 20 s) caused an increase in the intracellular levels of ROS.
The relative DCF fluorescence intensities measured after EtOH
exposure at 30, 60, 90, and 120 min were as follows: 30 min,
506.569.19%; 60 min, 30567.07%; 90 min, 142.5610.6%;
120 min, 126.068.49%. EtOH exposure caused an increase of at
least fivefold in intracellular ROS levels at min. CoQ10 pretreat-
ment reduced the ROS levels in EtOH-exposed cells at all time
points (30 min, 293.569.19%; 60 min, 19862.83%; 90 min,
Figure 1. The influence of CoQ10 on EtOH induced cell death in corneal fibroblasts. The cells were pretreated with 10 mM CoQ10 for 2 h.
Thereafter, EtOH (A–D: 0.4%, 2%, 4%, 20%, E: 20%) at indicated concentrations were added. After incubation period (2, 4, 8, or 12 h), the cell viability
was determined by MTT assay. Data represent the results of three independent experiments (means 6 SD; *P,0.05 compared with the control
group; {P,0.05 compared with the EtOH group).
doi:10.1371/journal.pone.0019111.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19111Figure 2. Pretreatment of corneal fibroblasts for 2 h with 10 mM CoQ10 inhibited the cell apoptosis induced by EtOH exposure.
(A–D) Cells were pretreated with or without CoQ10, followed by different EtOH treatment (0.4%, 2%, 4%, and 20%) for 20 s. The apoptotic cells were
stained with annexin V-PI for flow-cytometric analysis at 4, 8, and 12 h. (E) The bar diagram shows the comparison of the relative fluorescence of
annexin V–FITC fluorescence intensity at different times. Data represent the results of three independent experiments (means 6 SD; *P,0.05
compared with the control group; {P,0.05 compared with the EtOH group).
doi:10.1371/journal.pone.0019111.g002
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ROS levels were significantly lower in cells pretreated with CoQ10
at 30, 60, 90, and 120 min after exposure to EtOH (30 min,
P,0.0001; 60 min, P=0.01; 90 min, P=0.02; 120 min, P=0.02).
Effects of coenzyme Q10 on ethanol-treated cellular
mitochondrial membrane potential
The changes in the mitochondrial membrane potential of EtOH-
exposed (20%, 20 s) cells were determined by JC-1 staining. The
extranuclearmitochondriainthecellsofthecontrolgroupprimarily
emitted red fluorescence, whereas the mitochondria undergoing
mitochondrial membrane potential transition (MPT), which were
located diffusely throughout the whole cells, were detected as green
particles. Flow-cytometric analysis of MPT demonstrated that the
relative green signals (Figure 4) of the EtOH-exposed cells at 30, 60,
90, and 120 min were 19.763.0%, 16.662.6%, 17.561.20%, and
15.460.35%, respectively, and those of the CoQ10-pretreated cells
were 4.360.5%, 3.060.1%, 14.760.5%, and 12.960.4%, respec-
tively. EtOH exposure caused a significant change in the mitoch-
ondrial membrane potential (30 min, P=0.03; 60 min, P=0.02;
90 min, P=0.03; 120 min, P=0.03). Pretreatment with CoQ10
significantly reduced MPT in the corneal fibroblasts at 30
(P,0.001), 60 (P,0.001), 90 (P=0.04), and 120 min (P=0.02).
Effects of coenzyme Q10 on ethanol-treated cellular
caspase activity
To ascertain the effects of CoQ10 on the EtOH-induced
activation of caspases (caspase 2, caspase 3, caspase 8, and caspase
9), cytosolic lysates of cells pretreated with or without CoQ10 and
then exposed to EtOH (20%, 20 s) were used to measure the
catalytic activation of the caspases at 2, 4, and 8 h (Figure 5). In
the EtOH-exposed cells, the enzymatic activation of caspase 2 and
caspase 3 began 2 h after treatment. There was an increase of
about sixfold and twofold in caspase 3 and caspase 2 activity,
respectively, 2 h after EtOH exposure. CoQ10 pretreatment
significantly reduced the activation of caspase 2 and caspase 3 at
2 h after EtOH exposure (caspase 2, P=0.01; caspase 3, P=0.03).
In contrast, the activities of caspase 8 and caspase 9 were not
significantly different with or without CoQ10 pretreatment at 2, 4,
and 8 h after EtOH exposure.
Effects of coenzyme Q10 on ethanol-treated cellular
caspase expression
To confirm the inhibition of caspase activation by CoQ10
pretreatment, a western blot analysis was performed (Figure 6). In
the EtOH-exposed cells, the expression of active caspase 3 was
evident at 4 h in 0.4% and 2% EtOH group, at 2, 4 h in 4% and
20% EtOH groups (Figure 6A–6D). Pretreatment with CoQ10
decreased the expression of active caspase 3 (Figure 6A–6D). In
20% EtOH-exposed cells, the expression of active caspase 2 and
active caspase 3 was increased 2 h after treatment (Figure 6E, 6F).
CoQ10 pretreatment significantly reduced the expression of active
caspase 2 and active caspase 3 at 2 h after EtOH (20%) exposure
(caspase 2, P=0.01; caspase 3, P=0.02; Figure 6E–6F). The
expression of caspase 8 and caspase 9 did not differ at the indicated
time points with or without CoQ10 pretreatment (Figure 6G–6H).
Table 2. Effect of CoQ10 on cell apoptosis induced by EtOH in corneal fibroblasts.
Group Incubation period (h) Apoptotic rate
a (%) P value vs control P value vs EtOH group
Control 4 1
0.4% EtOH 4 7.062.6
b 0.02
CoQ10/0.4%EtOH 4 5.962.7 0.06
2% EtOH 4 4.362.1
b 0.03
CoQ10/2%EtOH 4 3.361.4 0.09
4% EtOH 4 6.262.3
b 0.02
CoQ10/4%EtOH 4 4.560.6 0.07
Control 8 1
0.4% EtOH 8 20.567.34
b 0.002
CoQ10/0.4%EtOH 8 17.362.31
c 0.008
2% EtOH 8 20.066.43
b 0.006
CoQ10/2%EtOH 8 17.064.12
c 0.005
4% EtOH 8 23.066.50
b 0.001
CoQ10/4%EtOH 8 16.261.50
c 0.003
Control 12 1
0.4% EtOH 12 21.862.0
b 0.005
CoQ10/0.4%EtOH 12 8.363.0
c 0.002
2% EtOH 12 21.863.76
b 0.005
CoQ10/2%EtOH 12 11.262.25
c 0.004
4% EtOH 12 23.162.45
b 0.003
CoQ10/4%EtOH 12 11.562.43
c 0.001
aCells were pretreated with 10 mM of CoQ10 before different concentrations of EtOH (0.4%, 2%, 4%) exposure for 20 s and then cell apoptosis was measured by flow
cytometry after 4, 8, and 12 h.
bP,0.05, compared with control group.
cP,0.05, compared with EtOH group.
doi:10.1371/journal.pone.0019111.t002
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The apoptosis of cultured corneal fibroblasts has been detected
dose- and time-dependently after treatment with dilute ethanol
[11]. Consistent with previous results, we also report the
apoptogenic effects of ethanol on cultured corneal fibroblasts. In
our study, apoptotic features were apparent in ethanol-treated cells
and could be demonstrated as cell membrane disruption, detected
with Annexin V staining. We found the phenomenon of EtOH-
induced apoptosis occurred in different concentrations of EtOH
treatment (ranging from 0.4% to 20%). While, in the presence of
CoQ10, the proportion of apoptotic cells decreased significantly.
CoQ10 exhibited the most remarkable protection in the cells
exposed to 20% EtOH. We also determined the potential
mechanisms of CoQ10 in modulating the apoptogenic pathways
of EtOH on corneal fibroblasts in vitro. These results show that
CoQ10 reduced mitochondrial depolarization, ROS production,
and the activation of caspase 2 and caspase 3 in corneal fibroblasts
after EtOH treatment. Our results suggest that CoQ10 plays an
antiapoptotic role under circumstances wherein corneal fibroblasts
are challenged with an external stressor, such as ethanol. This
protective effect was clearly demonstrated as increased cellular
viability and reduced cellular apoptosis.
In clinical practice of corneal delamination with ethanol to
remove corneal epithelium before PRK and LASEK, EtOH (20%)
is exposed to the cornea. Joo et al. have reported the
morphological and functional changes in the rat cornea after
20% EtOH exposure for 30 to 40 seconds. They found that the
number of central stromal cells decreased gradually after EtOH
exposure, meaning the corneal stromal cells did undergo cell death
or apoptosis [33]. Similarly, Lee et al. have observed TUNEL-
positive cells in the chick cornea stroma 4 h after 20% EtOH
exposure for 30 seconds. Transmission electron microscopy
showed similar evidence of apoptosis in the anterior stroma [34].
In addition, percutaneous injection of different concentrations of
ethanol (0.4–100%) has been proven to be effective for the
treatment of hepatocellular carcinoma by killing the hepatic cells
[35]. Clinical and experimental assessment has shown that the low
concentrations of ethanol (0.2–0.4%) effectively destroy hepatic
cells by inducing apoptosis [35,36]. According to these studies, we
explored the phenomenon of EtOH-induced cell apoptosis at
different concentrations of dilute EtOH (ranging from 0.4% to
20%) in cornea. Similarly, we revealed that EtOH-induced cell
apoptosis could be found at these concentrations. Although the
concentrations of the penetrating alcohol were uncertain, it is
possible that alcohol leaks through the basement membrane and
causes the stromal cells to undergo apoptosis.
The first stage of stromal wound healing in the cornea after
PRK and LASEK is stromal cell apoptosis, followed by stromal
cell proliferation and subsequent myofibroblast transformation
[6,7]. Therefore, to achieve uneventful wound healing and optimal
visual recovery, it is important to prevent the initiation of
keratocyte apoptosis during refractive surgery [8]. In our study,
we demonstrated that application of EtOH did contribute to the
apoptosis of corneal fibroblasts in corneal stroma, which might
further affect the wound healing process in vivo.
In the apoptotic signaling cascades, two different initiation
machineries play major roles in a variety of cell types: extrinsic
death-receptor-mediated signaling and intrinsic caspase family
cysteine-protease-mediated signaling [37,38]. The Fas/Fas L and
caspase 3 apoptotic pathway is thought to play a primary role in
acute ethanol-induced liver apoptosis in mice [39,40]. Pastorino
et al have demonstrated that mitochondrial depolarization and the
subsequent activation of the caspase-independent pathway occur
in ethanol-exposed hepatocytes [41]. In cerebellar granule
neurons, ethanol exposure induces strong increases in caspase 2,
3, 6, 8, and 9 activities [42]. In the present study, we found that
caspase 3 plays a critical role in the ethanol-induced apoptosis of
corneal fibroblasts [10,11]. We also demonstrated the inhibitory
effects of CoQ10 on caspase 3 and caspase 2, but not on caspase 8
or caspase 9. Here, the notion that ethanol induces apoptosis by
different pathways, depending on the cell type, can also be
extended to the apoptosis of corneal fibroblasts. The specific roles
of mitochondrial depolarization, oxidative stress, and caspase
activation after ethanol exposure warrant further investigation and
comparison in different cell types.
Mitochondria play major roles in cellular physiology beyond
their roles in electron transport and energy conservation. The
outer membrane and the intermembrane space, considered mere
accessories in classical mitochondrial physiology, are now
recognized as intimately involved in the control of apoptosis, the
process of controlled (programmed) cell death [43]. There is now
considerable evidence that ethanol treatment facilitates the
activation of MPT [43,44,45]. Ishii and coworkers reported that
acute ethanol treatment promotes apoptosis in primary hepatocyte
cultures in vitro, accompanied by ROS formation and mitochon-
drial depolarization, characteristic of MPT activation [45].
Mitochondrial dysfunction in apoptotic signaling after exposure
to ethanol has not been specifically addressed in the context of the
apoptosis of corneal fibroblasts, although altered mitochondrial
function has been reported in the corneal epithelium [10]. Our
study demonstrates for the first time that mitochondrial dysfunc-
tion in corneal fibroblasts occurs soon after ethanol exposure.
CoQ10 exerts its antiapoptotic effects by abrogating mitochondrial
disruption in ethanol-treated cells. We propose that the potential
mechanism by which CoQ10 inhibits mitochondrial dysfunction is
associated with the opening of the mitochondrial permeability
transition pore (PTP). Previous studies have demonstrated that the
Ca
2+-dependent opening of the PTP in isolated mitochondria can
be prevented by two synthetic quinine analogues [46,47], and the
structural features required for the regulation of the mitochondrial
PTP by ubiquinone analogues have been identified [48]. CoQ10 is
also reported to prevent the mitochondrial depolarization and
Figure 3. Pretreatment of corneal fibroblasts for 2 h with
10 mM CoQ10 reduced the elevated reactive oxygen species
(ROS) levels induced by EtOH exposure. ROS levels in cells
pretreated with or without CoQ10, followed by EtOH treatment (20%,
20 s), were measured by analyzing the DCF intensity after 30 min. Data
represent the results of three independent experiments performed in
triplicate (means 6 SD; *P,0.05 compared with the control group;
{P,0.05 compared with the EtOH group).
doi:10.1371/journal.pone.0019111.g003
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sequential events are related to the opening of the PTP, and lead
to mitochondria-dependent apoptosis.
Regarding ethanol-induced ROS formation, increased cellular
oxidative stress occurs during the acute and chronic ethanol
exposure of hepatocytes [50], the developing brain [51], and
cultured neurons [52]. Ethanol elicits a rapid increase in ROS,
which is ultimately followed by apoptotic cell death in cultured
neurons [53]. The proposed mechanisms of ethanol-induced ROS
formation include oxidative protein modification and enzyme
inactivation [54], antioxidant depletion [55], and mitochondrial
dysfunction [51], all of which may contribute to apoptotic cell
death [53]. It has been proposed that the inhibition of ROS
production by CoQ10 and other ubiquinones is mediated by the
regulation of mitochondrial depolarization [48]. Consistent with
previous studies, we found that the CoQ10 prevents both
mitochondrial depolarization and ROS production in EtOH-
exposed cells at similar time points. Based on these considerations,
CoQ10 plays an important role in modulating mitochondrial
depolarization and ROS production after the acute exposure of
cells to ethanol.
The management and response systems for cellular oxidative
stress involve a cascade of carefully maintained homeostatic
processes that depend on mitochondrial function after ethanol
treatment. The mitochondria are one of the important sources of
ROS in ethanol-exposed cells [50]. The resulting oxidative stress in
the mitochondria exerts its effects in part by damaging the
mitochondrial functions. The mitochondrial response is further
controlled by the activation of the MPT, and changes in the
mitochondrial potential induce caspase activation. Finally, the
consequences of mitochondrial depolarization lead to programmed
cell death. In this study, we found that the response systems after
ethanol treatment are affected by CoQ10 at different levels. CoQ10
can suppress the oxidative stress imposed on the mitochondria and
thereby suppresses the MPT. CoQ10 also prevents the activation of
caspasesand subsequentapoptosis.Ourfinding thatCoQ10protects
cells from mitochondria-dependent apoptosis is consistent with
those of one previous study [49]. The association and integration of
CoQ10 in the mitochondrial respiratory chain complexes suggest
that CoQ10plays a roleasa structural element andmodulatorofthe
mitochondria [32,46,47,48,49].
In the present study, we have demonstrated that CoQ10 exerts a
potent protective effect against ethanol-induced programmed cell
death by inhibiting mitochondrial depolarization and reducing
intracellular oxidative stress, caspase activity, and subsequent
apoptosis. Our results not only offer a more mechanistic
explanation of the antiapoptotic properties of CoQ10, but also
support further investigation of the clinical uses of CoQ10 in
treating and preventing the cell damage in the cornea induced by
ethanol exposure.
Materials and Methods
Culture of corneal fibroblasts
Primary corneal fibroblasts were obtained from fresh bovine
corneas by collagenase digestion, with a method modified from
that described by Funderburgh et al [56]. Briefly, the central
portions of fresh bovine corneas were incubated at 37uC in 2.4 U
of dispase II (Roche, Penzberg, Germany)/Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen-Gibco, USA) containing
antibiotics (penicillin, 50 mg/mL; streptomycin, 50 mg/mL; am-
photericin B, 2.5 mg/mL) for 3 h to remove the corneal epithelium
and endothelium. After dispase II digestion, the samples were
serially scraped with a plastic spatula (Cell Scraper, TPP,
Switzerland) in phosphate-buffered saline (PBS) to remove the
epithelial cells. The corneal endothelial cells and Descemet’s
membrane were peeled away in a sheet from the periphery to the
center of the inner surface of the cornea with fine forceps.
The tissue was rinsed twice with DMEM containing antibiotics.
It was then minced into several small parts (2–3 mm) and
incubated in a volume of 1 mL per corneal stoma of 2 mg/mL
(w/v) collagenase A (103-586, Roche, Penzberg, Germany) in
DMEM with antibiotics at 37uC for 12 h until the complete
disruption of the tissue. Nylon mesh (40 mm; Cell Strainer,
Falcon, USA) was used to filter the cell suspension. The filtered cell
suspension was incubated in 75 mL flasks at 37uC with 10% fetal
bovine serum (FBS; Invitrogen-Gibco) in 95% air/5% CO2. The
samples were serially trypsinized and passaged three times for the
experiments.
Treatment
Treatment with 10 mM CoQ10 dissolved in 0.04% Lutrol F217,
which was used as the vehicle to ensure the cellular uptake of this
hydrophobic molecule [49], was commenced 2 h before the
application of EtOH (Figure S1). Corneal fibroblasts cultured to
approximately 90% confluence were pretreated with or without
CoQ10 and then exposed to EtOH (0.4, 2, 4, and 20%) for 20 s.
EtOH was diluted in distilled water to yield indicated concentra-
tions of EtOH solution. Cells in the control group were treated
with medium only.
MTT assay
Cell viability was analyzed using the 3-(4,5-dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Cells (4610
4/
well) were grown overnight in 96-well plates, pretreated with or
without CoQ10, and then exposed to EtOH (0.4, 2, 4, and 20%)
for 20 s. After different incubation periods (2, 4, 8 h, or 12 h),
MTT (0.5 mg/mL) was added to each well. The samples were
incubated in the absence of light for 4 h, after which the medium
was removed. The precipitates were resuspended in 50 mLo f
DMSO. The absorbance was measured on a plate reader at
570 nm (or 540 nm). Each experiment was performed in triplicate.
The reduction in optical density caused by the EtOH treatment
was used as a measure of cell viability after it was normalized to
that of cells incubated in control medium, which were considered
100% viable [57].
Identification of apoptosis induced by ethanol
To examine the apoptosis in EtOH-exposed (0.4–20%, 20 s)
cells with or without 2 h of CoQ10 pretreatment, the cells were
washed twice with PBS and then incubated for 4, 8, or 12 h. The
cells were simultaneously subjected to annexin V and propidium
iodide (PI) assays. An annexin V–fluorescein isothiocyanate
Figure 4. Pretreatment of corneal fibroblasts for 2 h with 10 mM CoQ10 reduced the change in mitochondrial membrane potential
induced by EtOH exposure. The mitochondrial membrane potential transition (MPT) was determined in cells pretreated with or without CoQ10,
followed by EtOH treatment (20%, 20 s), after intervals of (A) 30, (B) 60, (C) 90, and (D) 120 min. Loss of mitochondrial membrane potential was
demonstrated by the change in JC-1-derived fluorescence from red (high potential as JC-1 aggregates) to green (low potential as JC-1 monomer).
(E) The bar diagram shows the relative JC-1 green fluorescence after normalization to control at all intervals. Data represent the results of three
independent experiments performed in triplicate (means 6 SD; *P,0.05 compared with the control group; {P,0.05 compared with the EtOH group).
doi:10.1371/journal.pone.0019111.g004
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e19111Figure 5. Pretreatment of corneal fibroblasts for 2 h with 10 mM CoQ10 prevented the activation of caspase 2 and caspase 3
induced by EtOH exposure. The activity of (A) caspase 2, (B) caspase 3, (C) caspase 8, and (D) caspase 9 in cells pretreated with or without CoQ10,
followed by EtOH treatment (20%, 20 s), was examined by colorimetric assay after intervals of 2, 4, and 8 h. Data represent the results of three
independent experiments performed in triplicate (means 6 SD; *P,0.05 compared with the control group; {P,0.05 compared with the EtOH group).
doi:10.1371/journal.pone.0019111.g005
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bind phosphatidylserine, which is translocated to the outer leaflet
of the plasma membrane during the early stages of cell apoptosis
[58]. Therefore, the apoptotic cells were only stained with annexin
V–FITC, whereas the necrotic cells were doubly stained for both
annexin V–FITC and PI. The cells were suspended in binding
buffer at a final cell concentration of 1610
5 cells/mL and
incubated with both annexin V–FITC and PI for 15 min in the
Figure 6. The effect of pretreatment of corneal fibroblasts with CoQ10 on the expression of active caspases. The cells were pretreated
with 10 mM CoQ10 for h and thereafter not exposed or exposed to different concentrations of EtOH (A: 0.4%, B: 2%, C: 4%, D–H: 20%) for 20 s.
Western blot analysis was performed after intervals of 2, 4, or 8 h. The panels showed representative blots of pro- and active forms of (A–D, F) caspase
3, (E) caspase 2, (G) caspase 8, and (H) caspase 9. b-Actin and a-tubulin were used as the loading controls.
doi:10.1371/journal.pone.0019111.g006
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cence-activated cell sorter analysis.
Determination of reactive oxygen species (ROS)
Intracellular ROS were measured based on the intracellular
peroxide-dependent oxidation of 29,79-dichlorodihydrofluorescein
diacetate (DCFH-DA; Molecular Probes, USA) to form the
fluorescent compound 29,79-dichlorofluorescein (DCF), as previ-
ously described [59]. The ROS levels were assessed early after
ethanol exposure, before the occurrence of apoptosis, as examined
by flow cytometry. The cells were seeded onto 48-well plates at a
density of 2610
4 cells/well and cultured for 48 h. After the cells
were washed twice with PBS, fresh medium with or without 10 mM
CoQ10 was added. The cells were incubated for 2 h and then
exposedtoEtOH (20%,20 s).DCFA-DA(20 mM)wasadded to the
cells, which were incubated for 30 min at 37uC. After 30, 60, 90,
and 120 min, the cells were harvested and resuspended in 50 mM
HEPES buffer (5 mM HEPES, [pH 7.4], 5 mM KCl, 140 mM
NaCl, 2 mM CaCl2, 1 mM MgCl2, and 10 mM glucose). The
fluorescence intensity was determined spectrofluorometrically
(Geminin EM), with excitation at 485 and emission at 530 nm.
Measurement of changes in mitochondrial membrane
potential (DYm)
To determine DYm, the cells were pretreated with or without
CoQ10 and then exposed to EtOH (20%, 20 s). After 30, 60, 90, or
120 min, 2 mM 5,59,6,69-tetrachloro-1,19,3,39-tetraethyl-benzimi-
dazolyl-carbocyanine iodide (JC-1; Molecular Probes, USA) was
added to the cells for 30 min. After the JC-1 was removed, the
cells were washed with PBS, harvested by trypsinization, and
resuspended in PBS. The amount of JC-1 retained by 10,000 cells
per sample was measured at 530 nm (green fluorescence) and
590 nm (red fluorescence) with a flow cytometer and analyzed
with Cell Quest Alias software. The changes in green fluorescence
were evaluated to determine DYm [60].
Caspase activity assay
To measure the levels of caspase activity, cells pretreated with or
without CoQ10 were exposed to EtOH (20%, 20 s). The caspase
levels were measured with Caspase-3/CPP32, Caspase-2, Cas-
pase-8, and Caspase-9 Colorimetric Assay Kits (BioVision, Palo
Alto, CA) at 2, 4, and 8 h after EtOH exposure. The cells were
resuspended in 100 mL of chilled lysis buffer and incubated on ice
for 10 min. After incubation, the cells were centrifuged for 1 min
in a microcentrifuge (10,000 6 g). The supernatant (cytosol
extract) was transferred to a fresh tube and left on ice. After
assessment of the protein concentration (bicinchoninic acid [BCA]
method), each cytosolic extract was diluted to a concentration of
50–200 mg protein/50 mL cell lysis buffer (1–4 mg/mL). The
samples were measured and aliquoted to provide a 2 6 reaction
buffer into a glass tube (assuming 50 mLo f26reaction buffer per
sample). A volume of 26reaction buffer containing 10 mM DTT
(50 mL) and 5 mL of the appropriate caspase substrate (4 mM) was
added to each sample (final concentration 200 mM). The
substrates used for the different caspases were DEVD-pNA for
caspase 3, VDVAD-pNA for caspase 2, IETD-pNA for caspase 8,
and LEHD-pNA for caspase 9. The samples were incubated for
2 h in the dark. The absorbance was measured on a plate reader
at 400 nm (or 405 nm).
Western blot analysis
For the western blot analysis, the corneal fibroblasts were treated
with or without CoQ10 and then exposed to EtOH (0.4, 2, 4, and
20%) for 20 s. After 2, 4, or 8 h, the cytosolic fractions were
prepared as reported previously [61]. The total protein concentra-
tionof each sample was measured using the BCA method. The total
cellprotein(40 mg)wasresolvedbySDS–PAGEon12%acrylamide
gels and blotted onto polyvinylidene difluoride membrane. The
blotted membrane was incubated with PBS/Tween 20 (0.05%)
solution containing 2% skim milk to block nonspecific antigens, and
then incubated with rabbit anti-human caspase 3, caspase 8, or
caspase 9 antibody (Cell Signaling, Denvers, MA) or rabbit anti-
human/mouse caspase 2 antibody (R&D Systems, Minneapolis,
MN) at room temperature for 1 h. After the primary antibody
reaction, the membranes were incubated with horseradish-perox-
idase-conjugated anti-rabbit IgG antibody (Cell Signaling), detected
by Chemiluminescence Reagent Plus (NEN, Boston, MA), and
exposed to film (BioMax MR, Kodak).
Statistical analysis
Values are expressed as means 6 SD. The statistical analysis
was performed with Student’s t test and one-way analysis of
variance (ANOVA) where appropriate. Statistical significance was
determined at the 0.05 level.
Supporting Information
Figure S1 10 mM of CoQ10 was the optimal concentra-
tion to prevent cell death after EtOH exposure. The cells
was pretreated with different concentration of CoQ10 (0, 1, 2, 5,
10, 20, and 40 mM) followed by EtOH exposure (20%, 20 s). The
cell viability was evaluated by MTT assay at 2, 4, 8, and 12 h. The
maximal cell viability was found when the cells were pretreated
with 10 mM of CoQ10 at all time points. Data represent the results
of three independent experiments performed in triplicate (means
6 SD; *P , 0.05).
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